Status:
UNKNOWN
Clinical Trial to Evaluate the Efficacy and Safety of MEDITOXIN® in Subject With Idiopathic Overactive Bladder
Lead Sponsor:
Medy-Tox
Conditions:
Overactive Bladder
Eligibility:
All Genders
20+ years
Phase:
PHASE3
Brief Summary
This study is for patients who have idiopathic overactive bladder symptoms. This study will evaluate efficacy and safety of Neuronox® against placebo.
Eligibility Criteria
Inclusion
- Male and female subjects aged above 20
- Patient with overactive bladder symptoms lasting at least 6 months
Exclusion
- Patient with a history of surgery or a disease that may affect bladder function.
Key Trial Info
Start Date :
August 23 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2021
Estimated Enrollment :
216 Patients enrolled
Trial Details
Trial ID
NCT04113941
Start Date
August 23 2019
End Date
August 1 2021
Last Update
July 28 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Konkuk University Hospital
Seoul, South Korea